sCD28, sCD80, sCTLA-4, and sBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection.

Saved in:
Bibliographic Details
Title: sCD28, sCD80, sCTLA-4, and sBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection.
Authors: Jubel JM; Clinic for Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany., Randau TM; Clinic for Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany., Becker-Gotot J; Institute of Experimental Immunology, University Hospital Bonn, Bonn, Germany., Scheidt S; Clinic for Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany., Wimmer MD; Clinic for Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany., Kohlhof H; Clinic for Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany., Burger C; Clinic for Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany., Wirtz DC; Clinic for Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany., Schildberg FA; Clinic for Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.
Source: Frontiers in immunology [Front Immunol] 2021 Aug 06; Vol. 12, pp. 687065. Date of Electronic Publication: 2021 Aug 06 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2021.687065